Rankings
▼
Calendar
ZTS Q4 2022 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena
ZTS
Zoetis Inc.
$54B
Q4 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$2.0B
+3.7% YoY
Gross Profit
$1.4B
66.3% margin
Operating Income
$690M
33.8% margin
Net Income
$461M
22.6% margin
EPS (Diluted)
$0.99
QoQ Revenue Growth
+1.9%
Cash Flow
Operating Cash Flow
$741M
Free Cash Flow
$570M
Stock-Based Comp.
$16M
Balance Sheet
Total Assets
$14.9B
Total Liabilities
$10.5B
Stockholders' Equity
$4.4B
Cash & Equivalents
$3.6B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2.0B
$2.0B
+3.7%
Gross Profit
$1.4B
$1.3B
+1.9%
Operating Income
$690M
$596M
+15.8%
Net Income
$461M
$414M
+11.4%
Revenue Segments
Horses
$4.8B
87%
Cattle
$377M
7%
Swine
$138M
3%
Poultry
$115M
2%
Fish
$61M
1%
Geographic Segments
United States Segment
$1.1B
55%
International Segment
$901M
45%
← FY 2022
All Quarters
Q1 2023 →